[HTML][HTML] … experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry

M Lucijanić, N Bušić, P Bistrović, I Papić… - Croatian medical …, 2022 - ncbi.nlm.nih.gov
… of remdesivir use/maximum level of oxygen support during hospital stay in non-remdesivir-treated
from clinical judgments for remdesivir use. The outcomes of interest were length of …

Mortality in SARS-CoV-2 hospitalized patients treated with Remdesivir: a nationwide, registry-based study in Italy

P Russo, E Tacconelli, PP Olimpieri, S Celant… - Viruses, 2022 - mdpi.com
hospital stay from a nationwide, registry-based cohort study of hospitalized patients with
COVID-19 treated with remdesivir after adjusting for major epidemiological and clinical features. …

[HTML][HTML] Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

S Tsuzuki, K Hayakawa, Y Uemura, T Shinozaki… - International Journal of …, 2022 - Elsevier
… Secondary outcomes were 30-day in-hospital mortality and the risk of invasive mechanical
… We assigned patients treated with remdesivir at Day 1 to the ‘start remdesivir’ regimen arm …

Association of remdesivir treatment with survival and length of hospital stay among US veterans hospitalized with COVID-19

ME Ohl, DR Miller, BC Lund, T Kobayashi… - JAMA network …, 2021 - jamanetwork.com
remdesivir treatment courses and time of hospital discharge, we plotted days from matching
to discharge among remdesivir … that remdesivir treatment was received in the hospital among …

Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19

BT Garibaldi, K Wang, ML Robinson… - JAMA network …, 2021 - jamanetwork.com
Remdesivir recipients had a shorter time to clinical improvement than matched controls without
remdesivir treatment … our 5-hospital health system from March 4 through August 29, 2020. …

Association of remdesivir treatment with mortality among hospitalized adults with COVID-19 in the United States

AP Chokkalingam, J Hayden, JD Goldman… - JAMA Network …, 2022 - jamanetwork.com
… Conclusions and Relevance In this retrospective cohort study using health insurance claims
and hospital chargemaster data, remdesivir treatment was associated with a significantly …

Remdesivir in very old patients (≥ 80 years) hospitalized with COVID-19: real world data from the SEMI-COVID-19 registry

JM Ramos-Rincon, MD López-Carmona… - Journal of Clinical …, 2022 - mdpi.com
… This work shows that remdesivir treatment in elderly patients was associated with lower …
those currently admitted to the hospital for COVID-19, treatment with remdesivir may improve the …

Efficacy of remdesivir in hospitalised COVID-19 patients in Japan: a large observational study using the COVID-19 Registry Japan

S Tsuzuki, K Hayakawa, Y Uemura, T Shinozaki… - medRxiv, 2021 - medrxiv.org
… We assigned patients treated with remdesivir at Day 1 to the ‘start remdesivir’ regimen
arm and other patients to both regimens. Assigning a patient to both arms simultaneously is …

Association of treatment with remdesivir and 30-day hospital readmissions in patients hospitalized with COVID-19

A Finn, A Jindal, SB Andrea, V Selvaraj… - The American journal of …, 2022 - Elsevier
… whether treatment with remdesivirremdesivir using inverse-probability of treatment weights
in a cohort of patients admitted to hospital during the COVID-19 pandemic at a large hospital

[HTML][HTML] Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3 …

F Ader, M Bouscambert-Duchamp, M Hites… - The Lancet infectious …, 2022 - thelancet.com
… The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial. We … remdesivir
plus standard of care compared with standard of care alone in patients admitted to hospital